London Daily

Focus on the big picture.
Wednesday, Jul 02, 2025

Austria and Denmark plan vaccines with Israel to bolster slow EU supply

Austria and Denmark plan vaccines with Israel to bolster slow EU supply

Austria and Denmark, chafing at the slow rollout of COVID-19 vaccines within the European Union, have joined forces with Israel to produce second-generation vaccines against mutations of the coronavirus.

The move by the two EU member states comes amid rising anger over delays in ordering, approving and distributing vaccines that have left the 27-member bloc trailing far behind Israel’s world-beating vaccination campaign.

Austrian Chancellor Sebastian Kurz said it was right that the EU procures vaccines for its member states but the European Medicines Agency (EMA) had been too slow to approve them and lambasted pharmaceutical companies’ supply bottlenecks.

“We must therefore prepare for further mutations and should no longer be dependent only on the EU for the production of second-generation vaccines,” the conservative chancellor said in a statement on Tuesday.

Danish Prime Minister Danish Mette Frederiksen was also critical of the EU’s vaccine programme.

“I don’t think it can stand alone, because we need to increase capacity. That is why we are now fortunate to start a partnership with Israel,” she told reporters on Monday.

When asked whether Denmark and Austria wanted to take unilateral action in obtaining vaccines, Frederiksen said: “You can call it that.”

The European Commission said member states were free to strike separate deals should they wish to. “It’s not that the strategy unravelled or it goes against the strategy, not at all,” spokesman Stefan de Keersmaecker said.

An EMA spokeswoman did not have an immediate comment.

FIRST MOVERS?


Kurz and Frederiksen are due to travel to Israel this week to see Israel’s rapid vaccine roll-out up close.

Israel, which was quick to sign contracts for and to approve vaccines from U.S. drug makers Pfizer and Moderna, has given 94 doses per 100 people and the EU just seven, according to monitoring by Our World in Data.

Prime Minister Benjamin Netanyahu, who has made the campaign a showcase of his bid for re-election on March 23, has spoken of “an international corporation for manufacturing vaccines”.

None of the three countries has significant vaccine making capacity, however, raising questions over how realistic their ambitions are to gain greater self-sufficiency.

A growing number of EU countries have placed side orders for vaccines from Russia and China, even though the EMA has yet to rule on whether they are both safe and effective.

Slovakia said on Monday it had ordered 2 million doses of Russia’s Sputnik V vaccine and expects half to arrive this month to help it end a surge in infections.

The neighbouring Czech Republic - tackling the worst COVID-19 outbreak of any EU country - is also considering ordering Russia’s Sputnik V.

Hungary, meanwhile, has taken delivery of a vaccine developed by China’s Sinopharm, with Prime Minister Viktor Orban announcing on Sunday that he had received the shot.

The three vaccines so far cleared for use in the EU, made by Pfizer and German partner BioNTech, Moderna and AstraZeneca, rely on production in countries including Germany, Britain, Switzerland, Belgium and the Netherlands.

Kurz said Austria and Denmark would work with Israel on vaccine production against mutations of the coronavirus and jointly research treatment options in an alliance called the First Movers Group.

The initiative, which seeks greater protection against future pandemics in addition to joint EU vaccine supply, follows Germany’s decision last month to set up a task force to address supply bottlenecks and boost local manufacturing.

Kurz invited pharmaceutical companies with a local presence including Pfizer, Valneva, Novartis, Polymun and Boehringer Ingelheim on Tuesday to discuss the new initiative.

Pfizer, which declined comment for this story, has said it will make 2 billion doses this year - 70% of them in the EU - and has conducted extensive research into their effectiveness against coronavirus variants.

A spokesman for Boehringer Ingelheim said its focus was not on human vaccines “but if we receive requests we will of course look into them.”

Newsletter

Related Articles

0:00
0:00
Close
Poland Implements Border Checks Amid Growing Migration Tensions
Political Dispute Escalates Between Trump and Musk
Emirates Airline Expands Market Share with New $20 Million Campaign
Amazon Reaches Milestone with Deployment of One Millionth Robot
US Senate Votes to Remove AI Regulation Moratorium from Domestic Policy Bill
Yulia Putintseva Calls for Spectator Ejection at Wimbledon Over Safety Concerns
Jury Deliberations in Diddy Trial Yield Partial Verdict in Serious Criminal Charges
House Oversight Committee Subpoenas Former Jill Biden Aide Amid Investigation into Alleged Concealment of President Biden's Cognitive Health
King Charles Plans Significant Role for Prince Harry in Coronation
Two Chinese Nationals Arrested for Espionage Activities Against U.S. Navy
Amazon Reaches Major Automation Milestone with Over One Million Robots
Extreme Heat Wave Sweeps Across Europe, Hitting Record Temperatures
Meta Announces Formation of Ambitious AI Unit, Meta Superintelligence Labs
Robots Compete in Football Tournament in China Amid Injuries
Trump Administration Considers Withdrawal of Funding for Hospitals Providing Gender Treatment to Minors
Texas Enacts Law Allowing Gold and Silver Transactions
China Unveils Miniature Insect-Like Surveillance Drone
OpenAI Secures Multimillion-Dollar AI Contracts with Pentagon, India, and Grab
Marc Marquez Claims Victory at Dutch Grand Prix Amidst Family Misfortune
Germany Votes to Suspend Family Reunification for Asylum Seekers
Elon Musk Critiques Senate Budget Proposal Over Job Losses and Strategic Risks
Los Angeles Riots ended with Federal Investigations into Funding
Budapest Pride Parade Draws 200,000 Participants Amid Government Ban
Southern Europe Experiences Extreme Heat
Xiaomi's YU7 SUV Launch Garners Record Pre-Orders Amid Market Challenges
Jeff Bezos and Lauren Sanchez's Lavish Wedding in Venice
Russia Launches Largest Air Assault on Ukraine Since Invasion
Education Secretary Announces Overhaul of Complaints System Amid Rising Parental Grievances
Massive Anti-Government Protests Erupt in Belgrade
Trump Ends Trade Talks with Canada Over Digital Services Tax
UK Government Softens Welfare Reform Plans Amid Labour Party Rebellion
Labour Faces Rebellion Over Disability Benefit Reforms Ahead of Key Vote
Jeff Bezos and Lauren Sánchez Host Lavish Wedding in Venice Amid Protests
Trump Asserts Readiness for Further Strikes on Iran Amid Nuclear Tensions
North Korea to Open New Beach Resort to Boost Tourism Economy
UK Labour Party Faces Internal Tensions Over Welfare Reforms
Andrew Cuomo Hints at Potential November Comeback Amid Democratic Primary Results
Curtis Sliwa Champions His Vision for New York City Amid Rising Crime Concerns
Federal Reserve Proposes Changes to Capital Rule Affecting Major Banks
EU TO HUNGARY: LET THEM PRIDE OR PREP FOR SHADE. ORBÁN TO EU: STAY IN YOUR LANE AND FIX YOUR OWN MESS.
Trump Escalates Criticism of Media Over Iran Strike Coverage
Trump Announces Upcoming US-Iran Meeting Amid Controversial Airstrikes
Trump Moves to Reshape Middle East Following Israel-Iran Conflict
Big Four Accounting Firms Fined in Exam Cheating Scandal
NATO Members Agree to 5% Defense Spending Target by 2035
Australia's Star Casino Secures $195 Million Rescue Package Amid Challenges
UK to Enhance Nuclear Capabilities with Acquisition of F-35A Fighter Jets
Russian Shadow Payments via Cryptocurrency Reach $9 Billion
Explosions Rock Doha as Iranian Missiles Target Qatar
“You Have 12 Hours to Flee”: Israeli Threat Campaign Targets Surviving Iranian Officials
×